Skip to main content
SpringerLink
Log in

What can rodent models tell us about cognitive decline in alzheimer’s disease?

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

The prolongation of life and the rapidly increasing incidence of Alzheimer’s disease have brought to the foreground the need for greater understanding of the etiology of the disease and the means to prevent or at least slow down the process. Out of this need the transgenic mouse and the production of synthetic amyloid peptides have been developed in an attempt to create experimental models of Alzheimer’s disease that will help our understanding of the cellular and molecular mechanisms by which the pathology leads to memory dysfunction and to test potential therapeutic strategies. Despite 10 or so years of reasonably intensive research with these models, both fall short of producing a viable and faithful model of the complete pathology of Alzheimer’s disease and the behavioral consequences are far from modelling the progressive decline in cognitive function. Here we review the advantages and the caveats associated with the two models in terms of the pathology, the associated memory dysfunction, and the effect on synaptic plasticity. Given the more recent advances that have been made in the understanding of the neurobiological changes that occur with the disease and with the consideration of other environmental effects, which have been clearly shown to have an impact on the progression of the disease in humans, we emphasis the advantage of pharmacological or environmental in transgenic mice or rodents injected with synthetic peptides that may prove to be more fruitful in our understanding of the memory deficits associated with the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arendash G. W., King D. L., Gordon M. N., Morgan D., Hatcher J. M., Hope C. E., and Diamond D. M. (2001) Progressive, age-related behavioural impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891, 42–53.

    Article  PubMed  CAS  Google Scholar 

  • Arendt T. (2001a) Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer’s disease. Int. J. Devl. Neurosci. 19, 231–245.

    Article  CAS  Google Scholar 

  • Arendt T. (2001b) Alzheimer’s disease as a disorder of mechanisms underlying structural brain self organisation. Neuroscience 4, 723–765.

    Article  Google Scholar 

  • Arriagada P. V., Growdon J. H., Hedley-White E. T., and Hyman B. T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42, 631–639.

    PubMed  CAS  Google Scholar 

  • Bales K. R., Verina T., Cummins D. J., et al. (1999) Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 96, 15,233–15,238.

    Article  CAS  Google Scholar 

  • Barrow C. J. and Zagorski M. G. (1991) Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science 253, 179–182.

    Article  PubMed  CAS  Google Scholar 

  • Bartoo G. T., Nochlin D., Chang D., Kim Y., and Sumi S. M. (1997) The mean Aβ load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56, 531–540.

    PubMed  CAS  Google Scholar 

  • Behl C., Davies J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817–827.

    Article  PubMed  CAS  Google Scholar 

  • Benzi G. and Moretti A. (1995) Are reactive oxygen species involved in Alzheimer’s disease? Neurobiol. Aging 16, 661–674.

    Article  PubMed  CAS  Google Scholar 

  • Berg L., McKeel Jr. D. W., Millar J. P., Baty J., and Morris J. C. (1993) Neuropathological indexes of Alzheimer’s disease in demented and nondemented persons aged 80 years and older. Arch. Neurol. 50, 349–358.

    PubMed  CAS  Google Scholar 

  • Borchelt D. R., Thinakaran G., Eckman C. B., et al. (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Abeta1–42/1–40 ratio in vitro and in vivo. Neuron 17, 1005–1013.

    Article  PubMed  CAS  Google Scholar 

  • Borchelt D. R., Ratovistsky T., van Lare J., Lee M. K., et al. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins? Neuron 19, 939–945.

    Article  PubMed  CAS  Google Scholar 

  • Bornemann K. D., Wiederhold K. H., Pauli C., et al. (2001) Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am. J. Pathol. 158, 63–73.

    PubMed  CAS  Google Scholar 

  • Braak H. and Braak E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259.

    Article  PubMed  CAS  Google Scholar 

  • Breitner J. C. S., Welsh K. A., Helms M. J., et al. (1995) Delayed onset of Alzheimer’s disease with non steriodian anti inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16, 523–530.

    Article  PubMed  CAS  Google Scholar 

  • Bruce A. J., Malfroy B., and Baudry M. (1996) β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA 93, 2312–2316.

    Article  PubMed  CAS  Google Scholar 

  • Bush A. I., Multhaup G., Moir R. D., et al. (1993) A novel zinc (II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer’s disease. J. Biol. Chem. 268, 16,190–16,112.

    Google Scholar 

  • Calhoun M. E., Wiederhold K. H., Abramowski D., et al. (1998) Neuron loss in APP transgenic mice. Nature 395, 755–756.

    Article  PubMed  CAS  Google Scholar 

  • Campion D., Flaman J. M., Brice A., et al. (1995) Mutations of the presenilin 1 gene in families with early-onset Alzheimer’s disease. Hum. Mol. Genet. 4, 2372–2377.

    Article  Google Scholar 

  • Carter D. B., Dunn E., McKinley D. D., et al. (2001) Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. Ann. Neurol. 50, 468–475.

    Article  PubMed  CAS  Google Scholar 

  • Castegna A., Aksenov M., Aksenova M., et al. (2002) Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. part 1: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 33, 562–571.

    Article  PubMed  CAS  Google Scholar 

  • Chapman P. F., White G. L., Jones M. W., et al. (1999) Impaired synaptic plasticity and learning aged amyloid precursor protein transgenic mice. Nature Neurosci. 2, 271–276.

    Article  PubMed  CAS  Google Scholar 

  • Check E. (2002) Nerve inflammation halts trials for Alzheimer’s drug. Nature 415, 462.

    Article  PubMed  CAS  Google Scholar 

  • Chen G., Chen K. S., Knox J., et al. (2000) A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer’s disease. Nature 408, 975–982.

    Article  PubMed  CAS  Google Scholar 

  • Chen S. Y., Wright J. W., and Barnes C. D. (1996) The neurochemical and behavioural effects of beta-amyloid peptide (25–35). Brain Res. 720, 54–60.

    Article  PubMed  CAS  Google Scholar 

  • Chishti M. A., Yand D-S, Janus C., Phinney A. L., et al. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276, 21,562–21,570.

    Article  CAS  Google Scholar 

  • Chui D. H., Tanahashi H., Ozawa K., et al. (1999) Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nature Med. 5, 560–564.

    Article  PubMed  CAS  Google Scholar 

  • Citron M., Westaway D., Xia W., et al. (1997) Mutant presenilins of Alzheimer’s disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67–72.

    Article  PubMed  CAS  Google Scholar 

  • Citron M., Eckman C. B., Diehl T. S., et al. (1998) Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein. Neurobiol Dis. 5, 107–116.

    Article  PubMed  CAS  Google Scholar 

  • Cleary J., Hittner J. M., Semotuk M., Mantyh P., and O’Hare E. (1995) Beta-amyloid(1–40) effects on behavior and memory. Brain Res. 682, 69–74.

    Article  PubMed  CAS  Google Scholar 

  • Combs C. K., Johnson D. E., Cannady S. B., Lehman T. M., and Landreth G. E. (1999) Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and prion proteins. J. Neurosci. 19, 928–939.

    PubMed  CAS  Google Scholar 

  • Cotman C. W., Pike C. J., and Copani A. (1992) beta-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol. Aging 13, 587–590.

    Article  PubMed  CAS  Google Scholar 

  • Cruts M., Hendriks L., and Van Broeckhoven C. (1996) The presenilin genes: a new gene family involved in Alzheimer’s disease pathology. Hum. Mol. Genet. 5, 1449–1455.

    PubMed  CAS  Google Scholar 

  • Cummings B. J., Pike C. J., Shankle R., and Cotman C. W. (1996) Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer’s disease. Neurobiol. Aging 17, 921–933.

    Article  PubMed  CAS  Google Scholar 

  • Czech C., Tremp G., and Pradier L. (2000) Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms. Progs. Neurobiol. 60, 363–384.

    Article  CAS  Google Scholar 

  • Delobette S., Privat A., and Maurice T. (1997) In vitro aggregation facilitates beta-amyloid peptide-(25–35)-induced amnesia in the rat. Eur. J. Pharmacol. 319, 1–4.

    Article  PubMed  CAS  Google Scholar 

  • DeStrooper B., Saftig P., Craessaerts K., et al. (1998) Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387–390.

    Article  CAS  Google Scholar 

  • Davies C. A., Mann D. M., Sumpter P. Q., And Yates P. O. (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease. J. Neurol. Sci. 78, 151–164.

    Article  PubMed  CAS  Google Scholar 

  • Dewachter I., Van Dorpe J., Smeijers L., et al. (2000) Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V7171 transgenic mice by a different mechanism than mutant Presenilin1. J. Neurosci. 20, 6452–6458.

    PubMed  CAS  Google Scholar 

  • Dickson D. W. (1997) The pathogenesis of senile plaques. J. Neuropath. Exp. Neurol. 56, 321–339.

    PubMed  CAS  Google Scholar 

  • Dineley K. T., Westerman M., Bui D., Bell K., Ashe K. H., and Sweatt J. D. (2001) β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer’s disease. J. Neurosci. 21, 4125–4133.

    PubMed  CAS  Google Scholar 

  • Dodart J. C., Meziane H., Mathis C., Bales K. R., Paul S. M., and Ungerer A. (1999) Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav. Neurosci. 113, 982–990.

    Article  PubMed  CAS  Google Scholar 

  • Dodart J. C., Mathis C., Saura J., Bales K. R., Paul S. M., and Ungerer A. (2000) Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice. Neurobiol. Dis. 7, 71–85.

    Article  PubMed  CAS  Google Scholar 

  • Dornan W. A., Kang D. E., McCampbell A., and Kang E. E. (1993) Bilateral injections of beta A(25–35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat. Neuroreport 5, 165–168.

    Article  PubMed  CAS  Google Scholar 

  • Duff K., Eckman C., Zehr C., et al. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713.

    Article  PubMed  CAS  Google Scholar 

  • Duff K., Knight H., Refolo L. M., et al. (2000) Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol. Dis. 7, 87–98.

    Article  PubMed  CAS  Google Scholar 

  • Dumery L., Bourdel F., Soussan Y., Fialkowsky A., Viale S., Nicolas P., and Reboud-Ravaux M. (2001) β-amyloid protein aggregation: its implication in the physiopathology of Alzheimer’s disease. Path. Biol. 49, 72–85.

    Article  CAS  Google Scholar 

  • El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C., and Loike J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716–719.

    Article  PubMed  Google Scholar 

  • Estus S., Tucker H. M., van Rooyen C., Wright S., Brigham E. F., Wogulis M., and Rydel R. E. (1997) Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant “apoptotic” pattern of gene induction. J. Neurosci. 17, 7736–7745.

    PubMed  CAS  Google Scholar 

  • Farrar L., Cupples L. A., van Duijn C. M., et al. (1995) Apolipoprotein E genotype in patients with Alzheimer’s disease: implications for risk of dementia among relatives. Ann. Neurol. 38, 797–808.

    Article  Google Scholar 

  • Fitzjohn S. M., Morton R. A., Keunzi F., et al. (2001) Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci. 21, 4691–4698.

    PubMed  CAS  Google Scholar 

  • Folstein M. F. and Whitehouse P. J. (1983) Cognitive impairment of Alzheimer disease. Neurobehav. Toxicol. Teratol. 5, 631–634.

    PubMed  CAS  Google Scholar 

  • Frautschy S. A., Hu W., Kim P., Miller S. A., Chu T., Harris-White M. E., and Cole G. M. (2001) Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiol. Aging 22, 993–1005.

    Article  PubMed  CAS  Google Scholar 

  • Friedlich A. L. and Butcher L. L. (1994) Involvement of free oxygen radicals in β-amyloidosis: an hypothesis. Neurobiol. Aging 15, 443–455.

    Article  PubMed  CAS  Google Scholar 

  • Fukuchi K., Kamino K., Deeb S. S., Smith A. C., Dang T., and Martin G. M. (1992) Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity. Biochem. Biophys. Res. Comm. 182, 165–173.

    Article  PubMed  CAS  Google Scholar 

  • Gahtan E. and Overmier J. B. (1999) Inflammatory pathogenesis in Alzheimer’s disease: biological mechanisms and cognitive sequeli. Neurosci. Biobehav. Rev. 23, 615–633.

    Article  PubMed  CAS  Google Scholar 

  • Games D., Adams D., Alessandrini R., et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527.

    Article  PubMed  CAS  Google Scholar 

  • Giovannelli L., Casamenti F., Scali C., Bartolini L., and Pepeu G. (1995) Differential effects of amyloid peptides beta-(1–40) and beta-(25–35) injections into the rat nucleus basalis. Neuroscience 66, 781–792.

    Article  PubMed  CAS  Google Scholar 

  • Giulian D. (1999) Microglia and the immune pathology of Alzheimer disease. Am. J. Hum. Genet. 65, 13–18.

    Article  PubMed  CAS  Google Scholar 

  • Goate A., Chartier H. M., Mullan M., et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704–706.

    Article  PubMed  CAS  Google Scholar 

  • Goedert M. J., Strittmatter J., and Roses A. D. (1994) Risky apolipoprotein in brain. Nature 372, 45–46.

    Article  PubMed  CAS  Google Scholar 

  • Gomez-Isla T., Hollister R., West H., et al. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease. Ann. Neurol. 41, 17–24.

    Article  PubMed  CAS  Google Scholar 

  • Gordon M. N., King D. L., Diamond D. M., et al. (2001) Correlation between cognitive deficits and Aß deposits in transgenic APP+PS1 mice. Neurobiol. Aging 22, 377–386.

    Article  PubMed  CAS  Google Scholar 

  • Gordon M. N., Holcomb L. A., Jantzen P. T., et al. (2002) Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1 + APP mouse. Exp. Neurol. 173, 183–195.

    Article  PubMed  CAS  Google Scholar 

  • Gotz J., Chen F., Barmettler R., and Nitsch R. M. (2001) Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 276, 529–534.

    Article  PubMed  CAS  Google Scholar 

  • Greenberg B. D., Ali S. M., Howland D., et al. (1993) Transgenic mouse studies of Alzheimer amyloid precursor. In Amyloid and Amyloidosis (Kisilevsky R., Benson E. D., Frangioni B., Gauldie J., Muckle T. J., and Young I. D., eds.), Parthenon publishing, New York, pp. 328–331.

    Google Scholar 

  • Greenberg B. D. (1995) The COOH-terminus of the Alzheimer amyloid Aβ peptides: Differences in length influences the process of amyloid deposition in Alzheimer brain, and tell us something about relationships among parenchymal and vessel-associated amyloid deposits. Amyloid: Int. J. Exp. Clin. Invest. 2, 195–203.

    CAS  Google Scholar 

  • Griffin W.S.T., Sheng J. G., and Mrak R. E. (1997) Inflammatory pathways. Implications in Alzheimer’s disease. In Molecular Mechanisms of Dementia (Wasco W. and Tanzi R. E., eds) Humana, Totowa, NJ, pp. 169–176.

    Google Scholar 

  • Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y. C., Zaidi M. S., and Wisniewski H. M. (1986a) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261, 6084–6089.

    PubMed  CAS  Google Scholar 

  • Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M., and Binder L. I. (1986b) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83, 4913–4917.

    Article  PubMed  CAS  Google Scholar 

  • Guénette S. Y. and Tanzi R. E. (1999) Progress toward valid transgenic mouse model for Alzheimer’s disease. Neurobiol. Aging 20, 201–211.

    Article  PubMed  Google Scholar 

  • Halliwell B. (1992) Oxygen radicals as key mediators in neurological disease: fact or fiction? Ann. Neurol. 32, S10-S15.

    Article  PubMed  CAS  Google Scholar 

  • Harris M. E., Hensley K., Butterfield D. A., Leedle R. A., and Carney J. M. (1995) Direct evidence of oxidative injury produced by the Alzheimer’s beta-amyloid peptide (1–40) in cultured hippocampal neurons. Expl. Neurol. 131, 193–202.

    Article  CAS  Google Scholar 

  • Hartley D. M., Walsh D. M., Ye C. P., Diehl T., Vasquez S., Vassilev P. M., Teplow D. B., and Selkoe D. J. (1999) Protofibrillar intermediates of amyloid β-protein induces acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876–8884.

    PubMed  CAS  Google Scholar 

  • Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., and Butter-field D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free-radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270–3274.

    Article  PubMed  CAS  Google Scholar 

  • Hesse L., Behr D., Masters C. L., and Multhaup G. (1994) The beta A4 amyloid precursor protein binding to copper. FEBS Lett. 349, 109–116.

    Article  PubMed  CAS  Google Scholar 

  • Higgins L. S., Catalano R., Quon D., and Cordell B. (1993) Transgenic mice expressing human β-APP751 but not mice expressing β-APP695 display early Alzheimer’s disease-like histopathology. Ann. NY Acad. Sci. 695, 224–227.

    Article  PubMed  CAS  Google Scholar 

  • Higgins L. S., Rodems J. M., Catalano R., Quon T., and Cordell B. (1995) Early Alzheimer disease-like histopathology increase in frequency with age in mice transgenic for β-APP751. Proc. Natl. Acad. Sci. USA 92, 4402–4406.

    Article  PubMed  CAS  Google Scholar 

  • Holcomb L., Gordon M. N., McGowan E., et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Med. 4, 97–100.

    Article  PubMed  CAS  Google Scholar 

  • Holcomb L. A., Gordon M. N., Jantzen P., Hsiao K., Duff K., and Morgan D. (1999) Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet. 29, 177–185.

    Article  PubMed  CAS  Google Scholar 

  • Horsburgh K., McCarron M. O., White F., and Nicoll J. A. (2000) The role of apolipoprotein E in Alzheimer’s disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol. Aging 21, 245–255.

    Article  PubMed  CAS  Google Scholar 

  • Hsia A. Y., Masliah E., McConlogue L., et al. (1999) Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228–3233.

    Article  PubMed  CAS  Google Scholar 

  • Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99–102.

    Article  PubMed  CAS  Google Scholar 

  • Hughes C. P., Berg L., Danziger W. L., Coben L. A., and Martin R. L. (1982) A new clinical scale for the staging of dementia. Br. J. Psychiat. 140, 566–572.

    CAS  Google Scholar 

  • Irizarry M., McNamara M., Fedorchak K., Hsiao K., and Hyman B. (1997a) APPsw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56, 965–973.

    PubMed  CAS  Google Scholar 

  • Irizarry M. C., Soriano F., McNamara M., Page K. J., Schenk D., Games D., and Hyman B. T. (1997b) Aβ deposition is associated with neuropil changes, but not with overt cell loss in the PDAPP transgenic mice. J. Neurosci. 17, 7053–7059.

    PubMed  CAS  Google Scholar 

  • Ishihara T., Hong M., Zhang B., Nakagawa Y., Lee M. K., Trojanowski J. Q., and Lee V. M. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751–762.

    Article  PubMed  CAS  Google Scholar 

  • Ishihara T., Zhang B., Higuchi M., Yoshiyama Y., Trojanowski J. Q., and Lee V. M. (2001) Agedependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am. J. Pathol. 158, 555–562.

    PubMed  CAS  Google Scholar 

  • Iwatsubo T. (1998) Aβ42, presenilins and Alzheimer’s disease. Neurobiol. Aging 19, 11–13.

    Article  Google Scholar 

  • Janus C., Pearson J., McLaurin J., et al. (2000a) Aβ peptide immunisation reduces behavioural impairement and plaques in a model of Alzheimer’s disease. Nature 408, 979–982.

    Article  PubMed  CAS  Google Scholar 

  • Janus C., D’Amelio S., Amitay O., et al. (2000b) Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol. Aging 21, 541–549.

    Article  PubMed  CAS  Google Scholar 

  • Jarrett J. T. and Landsbury P. T. (1993) Seeding “one-dimensional crystallisation” of amyloid: a pathogenic mechanism of Alzheimer’s disease and Scrapie? Cell 73, 1055–1058.

    Article  PubMed  CAS  Google Scholar 

  • Jin L. W., Ninomiya H., Roch J. M., Schubert D., Masliah E., Otero D. A., and Saitoh R. (1994) Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14, 5461–5470.

    PubMed  CAS  Google Scholar 

  • Johnson S. A., Rogers J., and Finch C E. (1989) APP-695 transcript prevalence is selectively reduced during Alzheimer’s disease in cortex and hippocampus but not in cerebellum. Neurobiol. Aging 10, 755–760.

    Article  PubMed  CAS  Google Scholar 

  • Johnson S. A., McNeill T., Cordell B., and Finch C. E. (1990) Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer’s disease. Science 248, 854–857.

    Article  PubMed  CAS  Google Scholar 

  • Johnson-Wood K., Lee M., Motter R., et al. (1997) Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 1550–1555.

    Article  PubMed  CAS  Google Scholar 

  • Jones M. W., Errington M. L., French P. J., et al. (2001) A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nature Neurosci. 4, 289–296.

    Article  PubMed  CAS  Google Scholar 

  • Kalback W., Watson M. D., Fitzjohn T. A., et al. (2002) APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer’s disease senile plaques. Biochemistry 41, 922–928.

    Article  PubMed  CAS  Google Scholar 

  • Kang J., Lemaire H. G., Unterbeck A., et al. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733–736.

    Article  PubMed  CAS  Google Scholar 

  • Kammesheidt A., Boyce F. M., Spanoyannis A. F., et al. (1992) Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice overexpressing the carboxyl-terminal fragment of Alzheimer precursor protein in the brain. Proc. Natl. Acad. Sci. USA 89, 10,857–10,861.

    Article  CAS  Google Scholar 

  • Katzman R., Terry R., De Teresa R., Brown T., Davies P., Fuld P., Renbing S., and Peck A. (1988) Clinical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous senile plaques. Ann. Neurol. 23, 138–144.

    Article  PubMed  CAS  Google Scholar 

  • Kawabata S., Higgins G. A., and Gordon J. W. (1991) Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing the C-terminal fragment of human amyloid precursor protein. Nature 354, 476–478.

    Article  PubMed  CAS  Google Scholar 

  • King D. L., Arendash G. W, Crawford F., Sterk T., Menendez J., and Mullan M. J. (1999) Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer’s disease. Behav. Brain Res. 103, 145–162.

    Article  PubMed  CAS  Google Scholar 

  • Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiro S., and Ito H. (1988) Novel precursor of Alzheimer’s disease amyloid protein show protease inhibitory activity. Nature 331, 530–532.

    Article  PubMed  CAS  Google Scholar 

  • Klein W. L., Krafft G. A., and Finch C. E. (2001) Targeting small Aβ oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci. 24, 219–224.

    Article  PubMed  CAS  Google Scholar 

  • Kosic K. S. (1999) A notable cleavage: Winding up with β-amyloid. Proc. Natl. Acad. Sci USA. 96, 2574–2576.

    Article  Google Scholar 

  • Kuo Y. M., Kokjohn T. A., Beach T. G., et al. (2001) Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer’s disease brains. J. Biol. Chem. 276, 12,991–12,998.

    CAS  Google Scholar 

  • Lambert M. P., Barlow A. K., Chromy B. A., et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448–6453.

    Article  PubMed  CAS  Google Scholar 

  • Larson J., Lynch G., Games D., and Seubert P. (1999) Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840, 23–35.

    Article  PubMed  CAS  Google Scholar 

  • Lee V. M., Balin B. J., Otvos L. Jr., and Trojanowski J. Q. (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251, 675–678.

    Article  PubMed  CAS  Google Scholar 

  • Lemere C. A., Lopera F., Koski K. S., et al. (1996) The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med. 2, 1146–1150.

    Article  PubMed  CAS  Google Scholar 

  • Lendon C. L., Ashall F., and Goate A. M. (1997) Exploring the aetiology of Alzheimer disease using molecular genetics. JAMA 277, 825–831.

    Article  PubMed  CAS  Google Scholar 

  • Levy-Lahad E., Wijsman E. M., Nemens E., et al. (1995a) A familial Alzheimer’s disease locus on chromosome 1. Science 269, 970–973.

    Article  PubMed  CAS  Google Scholar 

  • Levy-Lahad E., Wasco W., Poorkaj P., et al. (1995b) Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269, 973–977.

    Article  PubMed  CAS  Google Scholar 

  • Lewis J., Dickson D. W., Lin W. L., et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487–1491.

    Article  PubMed  CAS  Google Scholar 

  • Lim G. P., Yang F., Chu T., et al. (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer’s disease. J. Neurosci. 20, 5709–5714.

    PubMed  CAS  Google Scholar 

  • Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A., and Cole G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370–8377.

    PubMed  CAS  Google Scholar 

  • Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., and Cotman C. W. (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951–7955.

    Article  PubMed  CAS  Google Scholar 

  • Loring J. F., Wen X., Lee J. M., Seilhamer J., and Somogyi R. (2001) A gene expression profile of Alzheimer’s disease. Cell Biol. 20, 683–695.

    CAS  Google Scholar 

  • Lue L. F., Kuo Y. M., Roher A. E., et al. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am. J. Pathol. 155, 853–862.

    PubMed  CAS  Google Scholar 

  • MacGibbon G., Lawlor P., Walton M., et al. (1997) Expression of Fos, Jun and Krox family proteins in Alzheimer’s disease. Exp. Neurol. 147, 316–332.

    Article  PubMed  CAS  Google Scholar 

  • Malin D. H., Crothers M. K., Lake J. R., et al. (2001) Hippocampal injections of amyloid beta-peptide 1–40 impair subsequent one-trial/day reward learning. Neurobiol. Learn. Mem. 76, 125–137.

    Article  PubMed  CAS  Google Scholar 

  • Mandelkow E. M. and Mandelkow E. (1998) Tau in Alzheimer’s disease. Trends Cell Biol. 8, 425–427.

    Article  PubMed  CAS  Google Scholar 

  • Mangoni A., Grassi M. P., Frattola L., Piolti R., Bassi S., Motta A., Marcone A., and Smirne S. (1991) Effects of a MAO-B inhibitor in the treatment of Alzheimer’s disease. Eur. Neurol. 31, 100–107.

    PubMed  CAS  Google Scholar 

  • Masliah E., Sisk A., Mallory M., Mucke L., Shenk D., and Games D. (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer’s disease. J. Neurosci. 16, 5795–5811.

    PubMed  CAS  Google Scholar 

  • Mattson M. P. (1997) Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081–1132.

    PubMed  CAS  Google Scholar 

  • Mattson M. P. (2000) Apoptosis in neurodegenerative disorders. Nature Rev. Mol. Cell. Biol. 1, 120–129.

    Article  CAS  Google Scholar 

  • Mattson M. P, Duan W., Lee J., and Zhihong G. (2001) Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech. Aging Dev. 122, 757–778.

    Article  PubMed  CAS  Google Scholar 

  • Maurice T., Lockhart B. P., and Privat A. (1996) Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res. 706, 181–193.

    Article  PubMed  CAS  Google Scholar 

  • Maurice T., Su T. P., and Privat A. (1998) Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate β25–35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 83, 413–428.

    Article  PubMed  CAS  Google Scholar 

  • McDonald M. P., Dahl E. E., Overmier J. B., Mantyh P., and Cleary J. (1994) Effects of an exogenous β-amyloid peptide on retention for spatial learning. Behav. Neural Biol. 62, 60–67.

    Article  PubMed  CAS  Google Scholar 

  • McDonald M. P., Overmier J. B., Bandyopadhyay S., Babcock D., and Cleary J. (1996) Reversal of β-amyloid-induced retention deficit after exposure to training and state cues. Neurobiol. Learn. Mem. 65, 35–47.

    Article  PubMed  CAS  Google Scholar 

  • McDonald M. P. and Ovemier J. B. (1998) Present imperfect: A critical review of animal models of the mnemonic impairments in Alzheimer’s disease. Neurosci. Biobehav. Rev. 22, 99–120.

    Article  PubMed  CAS  Google Scholar 

  • McGeer P. L. and McGeer E. G. (1998) Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis. Assoc. Disord. 12, Suppl 2:S1-S6.

    PubMed  CAS  Google Scholar 

  • McGeer P. L. and McGeer E. G. (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22, 799–809.

    Article  PubMed  CAS  Google Scholar 

  • Mesulam M. M. (1999) Neuroplasticity failure in Alzheimer’s disease: bridging the gap between plaques and tangles. Neuron 24, 521–529.

    Article  PubMed  CAS  Google Scholar 

  • Moechars D., Dewachter I., Lorent K., et al. (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 6483–6492.

    Article  PubMed  CAS  Google Scholar 

  • Mohs R., Breitner J., Silverman J., and Davis K. L. (1987) Alzheimer’s disease-morbid risk among first degree relatives approximates 50% by 90 years of age. Arch. Gen. Psychiatry 44, 405–408.

    PubMed  CAS  Google Scholar 

  • Moran P. M., Higgins L. S., Cordell B., and Moser P. C. (1995) Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA 92, 5341–5345.

    Article  PubMed  CAS  Google Scholar 

  • Morgan D., Diamond D. M., Gottschall P. E., et al. (2000) Aβ peptide vaccination prevents the memory loss in an animal model of Alzheimer’s disease. Nature 408, 982–985.

    Article  PubMed  CAS  Google Scholar 

  • Morris J. C., McKeel D., Stordandt M., Rubin E. H., Price J. L., Grant E. A., Ball M. J., and Berg L. (1991) Very mild Alzheimer’s disease: information based clinical, psychometric, and pathological distinction from normal aging. Arch. Neurol. 12, 295–312.

    Google Scholar 

  • Morris J. C. (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43, 2141–2414.

    Google Scholar 

  • Morris J. C., Stordandt M., McKeel D. W., Rubin E. H., Price J. L., Grant E. A., and Berg L. (1996) Cerebral amyloid deposition and diffuse plaques in “normal” aging: evidence for presymptomatic and very mild Alzheimer’s disease. Neurology 46, 707–719.

    PubMed  CAS  Google Scholar 

  • Mucke L., Masliah E., Johnson W. B., et al. (1994) Synaptotrophic effects of human amyloid protein precursors in the cortex of transgenic mice. Brain Res. 666, 151–167.

    Article  PubMed  CAS  Google Scholar 

  • Mucke L., Masliah E., Yu G-Q., et al. (2000) High level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058.

    PubMed  CAS  Google Scholar 

  • Mudher A. and Lovestone S. (2002) Alzheimer’s disease-do tauists and baptists finally shake hands? Trends Neurosci. 25, 22–26.

    Article  PubMed  CAS  Google Scholar 

  • Mullan M., Crawford F., Axelman K., Houlden H., Lilus L., Winblad B., and Lannfelt L. (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of β-amyloid. Nature Genet. 1, 345–347.

    Article  PubMed  CAS  Google Scholar 

  • Murrell J., Farlow B., Ghetti B., and Benson MD. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254, 97–99.

    Article  PubMed  CAS  Google Scholar 

  • Nabeshima T. and Nitta A. (1994) Memory impairment and neuronal dysfunction induced by β-amyloid protein in rats. Tohoku J. Exp. Med. 174, 241–249.

    Article  PubMed  CAS  Google Scholar 

  • Nakamura S., Murayama N., Noshita T., Annoura H., and Ohno T. (2001) Progressive brain dysfunction following intracerebral infusion of beta(1–42) amyloid peptide. Brain Res. 912, 128–136.

    Article  PubMed  CAS  Google Scholar 

  • Nalbantoglu J., Tirado-Santiago G., Lahsïni A., et al. (1997) Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500–505.

    Article  PubMed  CAS  Google Scholar 

  • Naruse S., Thinakaran G., Luo J. J., et al. (1998) Effects of PS1 deficiency on a membrane protein trafficking in neurons. Neuron 21, 1213–1221.

    Article  PubMed  CAS  Google Scholar 

  • Naslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Greengard P., and Buxbaum J. D. (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283, 1571–1577.

    Article  PubMed  CAS  Google Scholar 

  • Nitta A., Itoh A., Hasegawa T., and Nabeshima T. (1994) β-amyloid protein-induced Alzheimer’s disease animal model. Neurosci. Lett 170, 63–66.

    Article  PubMed  CAS  Google Scholar 

  • Nitta A., Fukuta T., Hasegawa T., and Nabeshima T. (1997) Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn. J. Pharmacol. 73, 51–57.

    PubMed  CAS  Google Scholar 

  • O’Hare E., Weldon D. T., Mantyh P. W., et al. (1999) Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1–42). Brain Res. 815, 1–10.

    Article  PubMed  CAS  Google Scholar 

  • Ohyagi Y. and Tabira T. (1993) Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells. Brain Res. Mol. Brain Res. 18, 127–132.

    Article  PubMed  CAS  Google Scholar 

  • Pallitto M. M. and Murphy R. M. (2001) A mathematical model of the kinetics of β-amyloid fibril growth from the denatured state. Biophys. J. 81, 1805–1822.

    Article  PubMed  CAS  Google Scholar 

  • Paresce D. M., Chung H., and Maxfield F. R. (1997) Slow degradation of aggregates of the Alzheimer’s disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272, 29,390–29,397.

    Article  CAS  Google Scholar 

  • Pasinetti G. M. (2001) Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer’s disease dementia. J. Neurosci. Res. 15, 471–476.

    Article  Google Scholar 

  • Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207, 367–368.

    Article  PubMed  CAS  Google Scholar 

  • Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676–1687.

    PubMed  CAS  Google Scholar 

  • Pompl P. N., Mullan M. J., Bjugstad K., and Arendash G. W. (1999) Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer’s disease. J. Neurosci. Methods 87, 87–95.

    Article  PubMed  CAS  Google Scholar 

  • Probst A., Gotz J., Wiederhold K. H., et al. (2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. (Berl). 99, 469–481.

    Article  CAS  Google Scholar 

  • Prolla T. A. and Mattson M. P. (2001) Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. Trends Neurosci. Suppl. 24, S21-S31.

    Article  CAS  Google Scholar 

  • Puolivali J., Wang J., Heikkinen T., Heikkila M., Tapiola T., van Groen T., and Tanila H. (2002) Hippocampal Abeta42 levels correlate with spatial memory deficits in APP and PS1 double transgenic mice. Neurobiol. Dis. 9, 339–347.

    Article  PubMed  CAS  Google Scholar 

  • Qiao X., Cummins D. J., and S.M Paul. (2001) Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse. Eur. J. Neurosci. 14, 474–482.

    Article  PubMed  CAS  Google Scholar 

  • Quon D., Wang Y., Catalano R., Scardina J. M., Murakami K., and Cordell B. (1991) Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352, 239–241.

    Article  PubMed  CAS  Google Scholar 

  • Rapoport S. I. (1999) In vivo PET imaging and post mortem studies suggest potential reversible and irreversible stages of failure in Alzheimer’s disease. Eur. Arch. Psychiat. Clin. Neurosci. (Suppl) 249, 46–55.

    Article  Google Scholar 

  • Reisberg B., Ferris S. H., de Leon M. J., and Crook T. (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiat. 139, 1136–1139.

    PubMed  CAS  Google Scholar 

  • Rogaev E. I., Sherrington R., Rogaev E. A., et al. (1995) Familial Alzheimer’s disease in kindred’s with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type3 gene. Nature 376, 775–778.

    Article  PubMed  CAS  Google Scholar 

  • Roher A. E., Chaney M. O., Kuo Y. M., et al. (1996) Morphological and toxicity of Abeta-(1–42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer’s disease. J. Biol. Chem. 271, 20,631–20,635.

    CAS  Google Scholar 

  • Roses A. (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp Neurol. 53, 429–437.

    PubMed  CAS  Google Scholar 

  • Roses A. D. (1995) Apolipoprotein E genotyping in differential diagnosis, not prediction of Alzheimer’s disease. Ann. Neurol. 38, 6–14.

    Article  PubMed  CAS  Google Scholar 

  • Sabo T., Lomnitski L., Nyska A., Beni S., Maronpot R. R., Shohami E., Roses A. D., and Michaelson D. M. (2000) Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience 101, 879–84.

    Article  PubMed  CAS  Google Scholar 

  • Sandhu F. A., Salim M., and Zain S. B. (1991) Expression of the human β-amyloid protein of Alzheimer’s disease specifically in brains of transgenic mice. J. Biol. Chem. 266, 21,331–21,334.

    CAS  Google Scholar 

  • Sano M., Ernesto C., Thomas R. G., et al. (1997) A controlled trial of selegiline, alpha-tocopherol, or both and treatment for Alzheimer’s disease. The Alzheimer’s disease cooperative study. N. Engl. J. Med. 336, 1216–1222.

    Article  PubMed  CAS  Google Scholar 

  • Schellenberg G. D., Pericak-Vance M. A., Wijsman E. M., et al. (1991) Linkage analysis of familial Alzheimer disease, using chromosome 21 markers. Am. J. Hum. Genet. 48, 563–583.

    PubMed  CAS  Google Scholar 

  • Scheuner D., Eckman C., Jensen M., et al. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nature Med. 2, 864–870.

    Article  PubMed  CAS  Google Scholar 

  • Schonberger S. J., Edgar P. F., Kydd R., Faull R. L., and Cooper G. J. (2001) Proteomic analysis of the brain in Alzheimer’s disease: molecular phenotype of a complex disease process. Proteomics 1, 1519–1528.

    Article  PubMed  CAS  Google Scholar 

  • Selkoe D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer’s disease. Nature 399, A23-A31.

    Article  PubMed  CAS  Google Scholar 

  • Serpell L. C. (2000) Alzheimer’s amyloid fibrils: structure and assembly. Biochim. Biophys. Acta. 1502, 16–30.

    PubMed  CAS  Google Scholar 

  • Sherrington R., Rogaev E. I., Liang Y., et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375, 754–760.

    Article  PubMed  CAS  Google Scholar 

  • Sigurdsson E. M., Hejna M. J., Lee J. M., and Lorens S. A. (1995) beta-Amyloid 25–35 and/or quinolic acid injections into the basal forebrain of young male Fischer-344 rats: behavioral, neurochemical and histological effects. Behav. Brain Res. 72, 141–156.

    Article  PubMed  CAS  Google Scholar 

  • Sisodia S. S., Annaert W., Kim S-H., and De Strooper B. (2001) γ-secretase: never more enigmatic. Trends Neurosci 11 (Suppl) S2-S5.

    Article  Google Scholar 

  • Small D. H., Nurcombe V., Reed G., Clarris H., Moir R., Beyreuther K., and Masters C. L. (1994) A heparin-binding domain in the amyloid precursor of Alzheimer’s disease is involved in the regulation of neurite outgrowth. J. Neurosci. 14, 2117–2127.

    PubMed  CAS  Google Scholar 

  • Small D. H., Mok S. S., and Bornstein J. C. (2001) Alzheimer’s disease and Aβ toxicity: from top to bottom. Nature Rev. Neurosci. 2, 595–598.

    Article  CAS  Google Scholar 

  • Smith J. D., Sikes J., and Levin J. A. (1998a) Human apolipoprotein E allele-specific brain expressing transgenic mice. Neurobiol. Aging 19, 407–413.

    Article  PubMed  CAS  Google Scholar 

  • Smith D. H., Nakamura M., McIntosh T. K., et al. (1998b) Brain trauma induces massive hippocampal neuron death linked to a surge in β-amyloid levels in mice overexpressing mutant amyloid precursor protein. A. J. Pathol. 153, 1005–1010.

    CAS  Google Scholar 

  • Snowdon D. A., Kemper S. J., Mortimer J. A., Greiner L. H., Wekstein D. R., and Markesbery W. R. (1996) Linguistic ability in early life and cognitive function and Alzheimer’s disease in late life. Findings from the Nun Study. JAMA 275, 528–532.

    Article  PubMed  CAS  Google Scholar 

  • Soriano S., Lu D. C., Chandra S., Pietrzik C. U., and Koo E. H. (2001) The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases. J. Biol. Chem. 276, 29,045–29,050.

    Article  CAS  Google Scholar 

  • Spillantini M. G., Bird T. D., and Ghetti B. (1998) Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol. 8, 387–402.

    Article  PubMed  CAS  Google Scholar 

  • Spittaels K., Van den Haute C., Van Dorpe J., et al. (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 155, 2153–2165.

    PubMed  CAS  Google Scholar 

  • Stadelmann C., Deckwerth T. L., Srinivasan A., Bancher C., Bruck W., Jellinger K., and Lassmann H. (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer’s disease. Evidence for apoptotic cell death. Am. J. Pathol. 155, 1459–1466.

    PubMed  CAS  Google Scholar 

  • Stein T. D. and Johnson J. A. (2002) Lack of neurodegeneration in transgenic mice over expressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 22, 7380–7388.

    PubMed  CAS  Google Scholar 

  • Stéphan A., Laroche S., and Davis S. (2001) Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci. 12, 5703–5714.

    Google Scholar 

  • Stéphan A., Davis S., Salin H., Dumas S., Mallet J., and Laroche S. (2002a) Age-dependent differential regulation of genes encoding APP and α-synuclein in hippocampal synaptic plasticity. Hippocampus 12, 55–62.

    Article  PubMed  CAS  Google Scholar 

  • Stéphan A., Laroche S., and Davis S. (2003) Learning deficits and dysfunctional synaptic plasticity induced by aggregated amyloid peptides in the dentate gyrus are rescued by chronic treatment with indomethacin. Eur. J. Neurosci. 17, 1921–1927.

    Article  PubMed  Google Scholar 

  • Stern Y., Gurland B., Tatemichi T. K., Tang M. X., Wilder D., and Mayeux R. (1994) Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 271, 1004–1010.

    Article  PubMed  CAS  Google Scholar 

  • Stewart W. F., Kawas C., Corrada M., and Metter E. J. (1997) Risk of Alzheimer’s disease and duration of NSAID use. Neurology 48, 626–632.

    PubMed  CAS  Google Scholar 

  • Strittmatter W. J., Saunders A. M., Schmehel D., Pericak-Vance M. A., Enghild J., Salvesen G. S., and Roses A. D. (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer’s disease. Proc. Natl. Acad. Sci USA 90, 1977–1981.

    Article  PubMed  CAS  Google Scholar 

  • Strohmeyer R. and Rogers J. (2001) Molecular and cellular mediators of Alzheimer’s disease inflammation. J. Alzheimer’s Disease 3, 131–157.

    CAS  Google Scholar 

  • Sturcher-Pierrat C., Abramowski D., Duke M., et al. (1997) Two amyloid precursor protein transgenic models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13,287–13,292.

    Article  Google Scholar 

  • Sun M. K. and Alkon D. L. (2002) Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid(25–35). J. Neurophysiol. 87, 2441–2449.

    PubMed  CAS  Google Scholar 

  • Sweeney W. A., Luedtke J., McDonald M. P., and Overmier J. P. (1997) Intrahippocampal injections of exogenous beta-amyloid induces postdelay errors in an eight-arm radial maze. Neurobiol. Learn. Mem. 68, 97–101.

    Article  PubMed  CAS  Google Scholar 

  • Takashima A., Noguchi K., Sato K., Hoshino T., and Imahori K. (1993) Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 7789–7793.

    Article  PubMed  CAS  Google Scholar 

  • Takashima A., Murayama M., Murayama O., et al. (1998a) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. USA 95, 9637–9641.

    Article  PubMed  CAS  Google Scholar 

  • Takashima A., Honda T., Yasutake K., et al. (1998b) Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25–35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31, 317–323.

    Article  PubMed  CAS  Google Scholar 

  • Tanzi R. E., Vaula G., Romano D. M., et al. (1992) Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am. J. Hum. Genet. 51, 273–282.

    PubMed  CAS  Google Scholar 

  • Teasdale G. M., Nicoll J. A., Murray G., and Fiddes M. (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350, 1069–1071.

    Article  PubMed  CAS  Google Scholar 

  • Terranova J. P., Kan J. P., Storme J. J., Perreaut P., Le Fur G., and Soubrie P. (1996) Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non peptide neurotrophic compound. Neurosci. Lett. 213, 79–82.

    Article  PubMed  CAS  Google Scholar 

  • Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synaptic loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572–580.

    Article  PubMed  CAS  Google Scholar 

  • Tesseur I., Van Dorpe J., Bruynseels K., Bronfman F., Sciot R., Van Lommel A., and Van Leuven F. (2000) Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am J Pathol. 157, 495–510.

    Google Scholar 

  • Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., and Endo N. (1996) Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271, 6839–6844.

    Article  PubMed  CAS  Google Scholar 

  • Troncoso J. C., Martin L. J., Dal Forno G., and Kawas C. H. (1996) Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol. Aging 17, 365–371.

    Article  PubMed  CAS  Google Scholar 

  • Tsuji T. and Shimohama S. (2001) Analysis of the proteomic profiling of brain tissue in Alzheimer’s disease. Dis. Markers 17, 247–257.

    PubMed  CAS  Google Scholar 

  • Uryu K., Laurer H., McIntosh T., Pratico D., Martinez D., Leight S., Lee V.M-Y., and Trojanowski J. Q. (2002) Repetitive mild brain trauma accelerates Aβ deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J. Neurosci. 22, 446–454.

    PubMed  CAS  Google Scholar 

  • Vassar R., Bennett B., Babu-Khan S., et al. (1999) Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembranal aspartic protease BACE. Science 286, 735–741.

    Article  PubMed  CAS  Google Scholar 

  • Vassar R. and Citron C. (2000) Aβ-generating enzymes: recent advances in β-and γ-secretase research. Neuron 27, 419–422.

    Article  PubMed  CAS  Google Scholar 

  • Walker D. G., Lue L. F., and Beach T. G. (2001) Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging 22, 957–966.

    Article  PubMed  CAS  Google Scholar 

  • Walsh D. M., Hartley D. M., Kusumoto Y., et al. (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25,945–25,952.

    Article  CAS  Google Scholar 

  • Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolke M. S., Rowan M. J., and Selkoe D. J. (2002) Naturally secreted oligomers of amyloid b protein potently inhibit hippocampal long-term potentiation iv vivo. Nature 416, 535–539.

    Article  PubMed  CAS  Google Scholar 

  • Wang R., Sweeney D., Gandy S. E., and Sisodia S. S. (1996) The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 271, 31,894–31,902.

    CAS  Google Scholar 

  • Wang J., Dickson D. W., Trojanowski J. Q., and Lee V. M. (1999) The levels of soluble versus insoluble brain Abeta distinguish Alzheimer’s disease from normal and pathologic aging. Exp. Neurol. 158, 328–337.

    Article  PubMed  CAS  Google Scholar 

  • Wang H-W., Pasternak J. F., Kuo H., et al. (2002) Soluble oligomer of β amyloid (1–42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924, 133–140.

    Article  PubMed  CAS  Google Scholar 

  • Weldon D. T., Rogers S. D., Ghilardo J. R., et al. (1998) Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18, 2161–2173.

    PubMed  CAS  Google Scholar 

  • Westerman M. A., Cooper-Blacketer D., Mariash A., et al. (2002) The relation ship between Aβ and memory in the Tg2576 mouse model of Alzheimer’s disease. J. Neurosci. 22, 1858–1867.

    PubMed  CAS  Google Scholar 

  • White F., Nicoll J. A. R., Roses A. D., and Horburgh K. (2001) Impaired neuronal plasticity in transgenic mice expressing human Apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol. Dis. 8, 611–625.

    Article  PubMed  CAS  Google Scholar 

  • Winkler J., Connor D. J., Frautschy S. A., Behl C., Waite J. J., Cole G. M., and Thal L. J. (1994) Lack of long-term effects after beta-amyloid protein injections in rat brain. Neurobiol. Aging 15, 601–607.

    Article  PubMed  CAS  Google Scholar 

  • Wirak D. O., Bayner R., Ramabhadran T. V., et al. (1991) Deposits of amyloid β protein in the central nervous system of transgenic mice. Science 253, 323–325.

    Article  PubMed  CAS  Google Scholar 

  • Wisniewski T., Castano E. M., Golabek A., Vogel T., and Frangione B. (1994) Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 1030–1035.

    PubMed  CAS  Google Scholar 

  • Wolfe M., Xia W., Ostaszewski B. L., Diehl T. S., Kimberley W. T., and Selkoe D. J. (1999) Two transmembrane aspartates in presenilin-1 required for endoproteolysis and γ-secretase activity. Nature 398, 513–517.

    Article  PubMed  CAS  Google Scholar 

  • Wolozin B., Iwasaki K., Vito P., et al. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710–1713.

    Article  PubMed  CAS  Google Scholar 

  • Wong P. C., Zheng H., Chen H., et al. (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 378, 288–292.

    Article  Google Scholar 

  • Yamada K., Tanaka T., Han D., Senzaki K., Kameyama T., and Nabeshima T. (1999) Protective effects of idebonone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur. J. Neurosci. 11, 83–90.

    Article  PubMed  CAS  Google Scholar 

  • Yamaguchi Y. and Kawashima S. (2001) Effects of amyloid-beta-(25–35) on passive avoidance, radial-arm maze learning and choline acetyl-transferase activity in the rat. Eur. J. Pharmacol. 412, 265–272.

    Article  PubMed  CAS  Google Scholar 

  • Yan J. J., Cho J. Y., Kim K. L., Jung J. S., Huh S. O., Kim Y. H., and Song D. K. (2001) Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 133, 89–96.

    Article  PubMed  CAS  Google Scholar 

  • Yan S. D., Chen X., Fu J., et al. (1996) RAGE and amyloid β peptide neurotoxicity in Alzheimer’s disease. Nature 382, 685–692.

    Article  PubMed  CAS  Google Scholar 

  • Younkin S. G. (1995) Evidence that A beta 42 is the real culprit in Alzheimer’s disease. Ann. Neurol. 37, 287–288.

    Article  PubMed  CAS  Google Scholar 

  • Yu G., Nishimura M., Arawaka S., et al. (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407, 48–54.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Neurobiologie de l’Apprentissage, de la Mémoire et de la Communication, CNRS UMR 8620, Université Paris-Sud, 91405, Orsay, France

    Sabrina Davis & Serge Laroche

Authors
  1. Sabrina Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serge Laroche
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabrina Davis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, S., Laroche, S. What can rodent models tell us about cognitive decline in alzheimer’s disease?. Mol Neurobiol 27, 249–276 (2003). https://doi.org/10.1385/MN:27:3:249

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/MN:27:3:249

Index Entries

Search

Navigation